Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reinduction Chemotherapy Containing Carboplatin and Paclitaxel With or Without Epoetin Alpha in Recurrent Platinum Sensitive Ovarian Cancer, Cancer of the Fallopian Tube or Peritoneum

NCT00189371 is registered in ClinicalTrials.gov with AGO Study Group as lead sponsor.

NCT NCT00189371
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00189371 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reinduction Chemotherapy Containing Carboplatin and Paclitaxel With or Without Epoetin Alpha in Recurrent Platinum Sensitive Ovarian Cancer, Cancer of the Fallopian Tube or Peritoneum
Lead sponsor
AGO Study Group
Phase
Phase 3
Overall status
Terminated
Start date
February 29, 2004
Completion date
December 31, 2005
Enrollment
300
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anemia, epithelial ovarian cancer, fallopian tube or peritoneum, platinum sensitve relapse